Population Pharmacokinetics of Palivizumab, a Humanized Anti-Respiratory Syncytial Virus Monoclonal Antibody, in Adults and Children

समान संसाधन

• Population Pharmacokinetics of Palivizumab, a Humanized Anti-Respiratory Syncytial Virus Monoclonal Antibody, in Adults and Children
  द्वारा: Robbie, Gabriel J., और अन्य
  प्रकाशित: (2012)
• Population Pharmacokinetics of Sifalimumab, an Investigational Anti-Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus
  द्वारा: Narwal, Rajesh, और अन्य
  प्रकाशित: (2013)
• Analysis of Respiratory Syncytial Virus Preclinical and Clinical Variants Resistant to Neutralization by Monoclonal Antibodies Palivizumab and/or Motavizumab
  द्वारा: Zhu, Qing, और अन्य
  प्रकाशित: (2011)
• Respiratory Syncytial Virus-Neutralizing Monoclonal Antibodies Motavizumab and Palivizumab Inhibit Fusion
  द्वारा: Huang, Kelly, और अन्य
  प्रकाशित: (2010)
• Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection
  द्वारा: Resch, Bernhard
  प्रकाशित: (2017)